Join the Oncology Voice Network. Join for Free
The transition from individual contributor to Medical Affairs leader with Gina Ferrari
pharmaceutical industry MSL manager role career advancement strategies leadership development programs internal networking

The transition from individual contributor to Medical Affairs leader with Gina Ferrari


Share This Article


Summary

In this episode, Gina Ferrari shares her journey into the pharmaceutical industry and her progression to an MSL manager role. She provides insights on career advancement strategies, emphasizing the value of taking on additional responsibilities and the impact of mentorship on career development. Gina discusses leadership development programs and the importance of mastering internal networking and company politics. She highlights the need for flexibility and effective communication in supporting team goals while balancing leadership responsibilities. The episode concludes with Gina's advice on documenting achievements and a look towards the future.

My guest today is Gina Ferrari, National Director MSLs and we discuss her transition from Individual Contributor to Medical Affairs Leadership.

In this episode:

  • Gina’s background
  • How she transitioned from an MSL to a Medical Affairs Leader
  • Skills to be developed in preparation for promotion and how MSLs can position themselves the same way Gina did
  • Finding mentors
  • Management training programs
  • Importance of internal networking
  • Gina’s advice for people to help them get noticed and the steps to follow

Click for Source
pharmaceutical industry, MSL manager role, career advancement strategies, leadership development programs, internal networking

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration
OVN Avatar Natansh D. Modi, BPharm; Ahmad Y. Abuhelwa, PhD; Ross A. McKinnon, PhD

Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration

Article
Job Search Checklist for Aspiring Medical Science Liaisons
Partner Avatar Tom Caravela

Job Search Checklist for Aspiring Medical Science Liaisons

Podcast
No “D”…No Problem: Finding Success WITHOUT a Doctorate
Partner Avatar MSL Talk: Tom Caravela, Greg Auclair

No “D”…No Problem: Finding Success WITHOUT a Doctorate

Podcast
Change Management: How Pharma SHOULD Handle Bad News
Partner Avatar MSL Talk: Tom Caravela, Alicia Bullock

Change Management: How Pharma SHOULD Handle Bad News

Press Release
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
OVN Avatar OVN Staff

Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Explore OVN